Alaunos Therapeutics (TCRT) Stock Chart & Stock Price History → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free TCRT Stock Alerts $1.16 -0.06 (-4.92%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alaunos Therapeutics Stock Price Performance5 Day Performance-2.52%1 Month Performance+3.57%3 Month Performance-24.68%6 Month Performance+0.17%Year-To-Date Performance+9.38%1 Year Performance-87.72% Receive TCRT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… TCRT Stock Chart for Monday, May, 20, 2024 TCRT Chart by TradingView Alaunos Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.22$1.16-4.92%$1.22$1.1427,664 shs$18.57 million05/16/2024$1.19$1.22+2.52%$1.33$1.05111,441 shs$19.53 million05/15/2024$1.29$1.19-7.39%$1.29$1.1319,917 shs$19.05 million05/14/2024$1.27$1.29+1.18%$1.32$1.2418,735 shs$20.57 million05/13/2024$1.24$1.27+2.42%$1.28$1.2030,789 shs$20.33 million05/10/2024$1.33$1.24-6.77%$1.32$1.1847,412 shs$19.85 million Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$1.29$1.33+3.10%$1.42$1.2829,610 shs$21.29 million05/08/2024$1.30$1.29-0.77%$1.35$1.2613,033 shs$20.65 million05/07/2024$1.32$1.30-1.52%$1.38$1.2544,035 shs$20.81 million05/06/2024$1.30$1.32+1.54%$1.38$1.2459,381 shs$20.82 million05/03/2024$1.36$1.30-4.41%$1.40$1.2625,343 shs$20.81 million05/02/2024$1.31$1.36+3.82%$1.42$1.3528,988 shs$21.77 million05/01/2024$1.26$1.31+3.97%$1.34$1.2720,308 shs$20.97 million04/30/2024$1.33$1.26-5.26%$1.36$1.2146,562 shs$20.17 million04/29/2024$1.32$1.33+0.76%$1.40$1.2645,353 shs$21.29 million04/26/2024$1.16$1.32+13.79%$1.34$1.1350,846 shs$21.13 million04/25/2024$1.18$1.16-1.69%$1.20$1.079,252 shs$18.57 million04/24/2024$1.20$1.18-1.67%$1.30$1.1730,377 shs$18.89 million04/23/2024$1.09$1.20+10.09%$1.23$1.0346,272 shs$19.21 million04/22/2024$1.12$1.09-2.68%$1.19$0.9838,153 shs$17.45 million04/19/2024$1.23$1.12-8.94%$1.26$1.1049,707 shs$17.93 million04/18/2024$1.24$1.23-0.81%$1.28$1.2033,072 shs$19.69 million04/17/2024$1.29$1.24-3.88%$1.39$1.2044,111 shs$19.85 million04/16/2024$1.40$1.29-7.86%$1.40$1.2593,278 shs$20.65 million04/15/2024$1.61$1.40-13.04%$1.57$1.3468,115 shs$22.41 million04/12/2024$1.67$1.61-3.59%$1.67$1.5551,530 shs$25.78 million04/11/2024$1.71$1.67-2.34%$1.74$1.6358,837 shs$26.74 million04/10/2024$1.73$1.71-1.16%$1.75$1.6733,367 shs$27.38 million04/09/2024$1.66$1.73+4.22%$1.76$1.6544,988 shs$27.70 million04/08/2024$1.71$1.66-2.92%$1.80$1.6560,532 shs$26.58 million04/05/2024$1.78$1.71-3.93%$1.80$1.6525,584 shs$27.38 million04/04/2024$1.82$1.78-2.20%$1.82$1.7328,535 shs$28.50 million04/03/2024$1.76$1.82+3.41%$1.85$1.6932,764 shs$29.21 million04/02/2024$1.75$1.76+0.57%$1.81$1.6961,053 shs$28.25 million04/01/2024$1.81$1.75-3.31%$1.89$1.65181,079 shs$28.09 million03/29/2024$1.81$1.81$1.88$1.8070,165 shs$29.05 million03/28/2024$1.86$1.81-2.69%$1.88$1.8070,159 shs$29.05 million03/27/2024$1.89$1.86-1.59%$1.90$1.8224,710 shs$29.85 million03/26/2024$1.91$1.89-1.05%$1.98$1.8627,835 shs$30.33 million03/25/2024$1.86$1.91+2.69%$1.97$1.8059,690 shs$30.66 millionMust-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story…03/22/2024$1.92$1.86-3.12%$1.95$1.7961,772 shs$29.85 million03/21/2024$1.79$1.92+7.26%$2.03$1.76124,053 shs$30.82 million03/20/2024$1.80$1.79-0.56%$1.89$1.6873,965 shs$28.73 million03/19/2024$1.75$1.80+2.86%$1.90$1.7552,252 shs$28.89 million03/18/2024$1.71$1.75+2.34%$1.98$1.7177,578 shs$28.09 million03/15/2024$1.64$1.71+4.27%$1.78$1.62102,083 shs$27.45 million03/14/2024$1.63$1.64+0.61%$1.67$1.5285,166 shs$26.32 million03/13/2024$1.65$1.63-1.21%$1.71$1.6325,542 shs$26.16 million03/12/2024$1.77$1.65-6.78%$1.80$1.6349,792 shs$26.48 million03/11/2024$1.90$1.77-6.84%$2.00$1.7439,208 shs$28.41 million03/08/2024$1.89$1.90+0.53%$2.00$1.8635,874 shs$30.50 million03/07/2024$1.88$1.89+0.53%$1.97$1.8448,298 shs$30.33 million03/06/2024$2.07$1.88-9.18%$2.02$1.80106,119 shs$30.17 million03/05/2024$2.20$2.07-5.91%$2.25$2.03105,684 shs$33.22 million03/04/2024$2.24$2.20-1.57%$2.28$2.0959,673 shs$35.31 million03/01/2024$2.09$2.24+6.94%$2.25$2.0827,800 shs$35.87 million02/29/2024$2.35$2.09-11.06%$2.32$2.08107,473 shs$33.54 million02/28/2024$2.16$2.35+8.80%$2.60$2.16245,595 shs$37.72 million02/27/2024$2.24$2.16-3.36%$2.33$2.13156,045 shs$34.67 million02/26/2024$1.93$2.24+15.80%$2.29$1.81262,708 shs$35.87 million02/23/2024$1.50$1.93+28.67%$2.00$1.49213,696 shs$30.98 million02/22/2024$1.40$1.50+7.14%$1.50$1.3647,438 shs$24.08 million02/21/2024$1.54$1.40-9.09%$1.60$1.3483,545 shs$22.47 million02/20/2024$1.71$1.54-9.94%$1.72$1.54115,235 shs$24.72 million02/19/2024$1.71$1.71$1.73$1.5479,900 shs$27.45 million Related Companies: Lumos Pharma Stock Price Chart Orgenesis Stock Price Chart Synlogic Stock Price Chart MEI Pharma Stock Price Chart BioVie Stock Price Chart NeuroBo Pharmaceuticals Stock Price Chart KALA BIO Stock Price Chart Benitec Biopharma Stock Price Chart Cocrystal Pharma Stock Price Chart Cumberland Pharmaceuticals Stock Price Chart Receive TCRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.